To compare endoscopic stenting with surgical bypass in patients with unresectable, malignant, distal common bile duct obstruction.
Data extraction
Tables presented in the review include the following data: patient inclusion and exclusion criteria; time of randomisation; method of randomisation; advance sample size calculation; number of patients per treatment arm; mean age; number of men; percentage in whom cancer was confirmed pathologically; and surgical procedure. Data were extracted by two of the authors, one of whom was blinded to the identity and institutional affiliations of the investigators. Investigators were contacted for additional data and for data not presented in the initial report (only one investigator from one study responded).
For each study the relative odds (OR) and 95% confidence interval (CI) of outcome (number of treatment failures, serious complications, patients requiring additional treatment, and deaths in first 30 days after treatment) were calculated for stent relative to surgery.
Methods of synthesis
How were the studies combined? Where there was no evidence of statistical heterogeneity across studies, the Mantel-Haenszel method was used to estimate a pooled OR. Where statistical heterogeneity was detected, the studies were combined in a narrative review. All results were presented as forest plots.
How were differences between studies investigated?
The Breslow-Day test was used to assess statistical heterogeneity.
Results of the review
Three RCTs were included in the review (303 patients).
All 3 studies scored 7 or more for validity and were judged to be of adequate quality. Methodological problems included small sample size, poorly defined outcomes and inadequate blinding. No studies that used metallic expandable stents were identified.
Evidence of statistical heterogeneity was found across studies for rates of treatment failure and serious complications; summary ORs were, therefore, not calculated.
Significantly more treatment sessions were required after stent replacement than after surgery. There was no statistically-significant difference in 30-day mortality between patients receiving stents or surgical bypass.
Treatment failure: 2 RCTs showed no significant difference between treatment groups and 1 RCT showed lower odds for the stent group. Heterogeneity was significant (p=0.041).
Serious complications: in 2 RCTs, serious complications were less common in the surgery group, whereas in the other study, complications were less common in the stent group. Heterogeneity was significant (p=0.021).
Number of additional treatment sessions: significantly more treatment sessions were required after stent replacement than after surgery. All 3 studies found that the stent group required significantly more treatment sessions compared to the surgery group. OR favouring stents was 7.23 (95% CI: 3.73, 13.98; heterogeneity, p=0.98). Thirty-day mortality: there was no statistically-significant difference in 30-day mortality between patients receiving stents or surgical bypass (OR 0.522, 95% CI: 0.263, 1.036).
